You are here: All Products  > Sanofi Invests in Graviton and its Lead Product, a ROCK2 Inhibitor in-licensed from Beijing Tide

Sanofi Invests in Graviton and its Lead Product, a ROCK2 Inhibitor in-licensed from Beijing Tide

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products